Danazol linked to ovarian cancer
article
OA: closed
CC0
⤵ 5 in-corpus citations
Limited metadata. Only one source feed has indexed
this record so far — no abstract, full text, or open-access copy is
available through Endo Lab. The
publisher's page (linked below)
is the canonical location for the actual content. If you have institutional
access, use "Find at my library".
AI-generated summary
This paper investigates a potential link between danazol use and an increased risk of ovarian cancer, presenting findings on the observed association.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
Cited by (5)
- Possible treatment-associated cancer in endometriosis 2020
- Clinical manifestations in patients with ovarian clear cell carcinoma with or without co-existing endometriosis 2009
- Danazol 2007
- Role of immunologic and inflammatory factors in the development of endometriosis: indications for treatment strategies 2005
- Role of immunologic and inflammatory factors in the development of endometriosis: indications for treatment strategies 2005
Source provenance
- europepmc
- last seen: 2026-08-16T09:21:09.727480+00:00
- openalex
- last seen: 2026-05-10T10:55:00.350230+00:00
- pubmed
- last seen: 2026-05-13T22:13:07.520820+00:00
- unpaywall
- last seen: 2026-08-21T06:37:11.537704+00:00
License: CC0
· commercial use OK